• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌及其类似物的不典型表现:如何使用钆塞酸增强肝脏磁共振成像解决具有挑战性的病例。

Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.

机构信息

Department of Radiology, Seoul National University Hospital, Seoul, Korea.

Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636.

DOI:10.3348/kjr.2018.0636
PMID:31270973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6609440/
Abstract

Hepatocellular carcinoma (HCC) can be diagnosed noninvasively with contrast-enhanced dynamic computed tomography, magnetic resonance imaging, or ultrasonography on the basis of its hallmark imaging features of arterial phase hyperenhancement and washout on portal or delayed phase images. However, approximately 40% of HCCs show atypical imaging features, posing a significant diagnostic challenge for radiologists. Another challenge for radiologists in clinical practice is the presentation of many HCC mimickers such as intrahepatic cholangiocarcinoma, combined HCC-cholangiocarcinoma, arterioportal shunt, and hemangioma in the cirrhotic liver. The differentiation of HCCs from these mimickers on preoperative imaging studies is of critical importance. Hence, we will review the typical and atypical imaging features of HCCs and the imaging features of its common mimickers. In addition, we will discuss how to solve these challenges in practice.

摘要

肝细胞癌 (HCC) 可以通过增强动态计算机断层扫描、磁共振成像或超声检查,根据其标志性的影像学特征,即动脉期增强和门静脉或延迟期图像的洗脱来进行非侵入性诊断。然而,约 40%的 HCC 表现出不典型的影像学特征,这对放射科医生来说是一个重大的诊断挑战。放射科医生在临床实践中面临的另一个挑战是,许多 HCC 的类似物,如肝内胆管细胞癌、合并 HCC-胆管细胞癌、动静脉分流和肝硬化中的血管瘤,在术前影像学研究中表现出类似 HCC 的特征。因此,术前影像学研究中区分 HCC 与这些类似物至关重要。因此,我们将回顾 HCC 的典型和不典型影像学特征及其常见类似物的影像学特征。此外,我们将讨论如何在实践中解决这些挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/dd193221c5c7/kjr-20-1019-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/4cf9958e10de/kjr-20-1019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/85a2687b5665/kjr-20-1019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/dd33e2d2bc71/kjr-20-1019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/4b4a36385502/kjr-20-1019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/a185b474c1e5/kjr-20-1019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/37e7c27f60a1/kjr-20-1019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/b8da6debcb6f/kjr-20-1019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/dd193221c5c7/kjr-20-1019-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/4cf9958e10de/kjr-20-1019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/85a2687b5665/kjr-20-1019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/dd33e2d2bc71/kjr-20-1019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/4b4a36385502/kjr-20-1019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/a185b474c1e5/kjr-20-1019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/37e7c27f60a1/kjr-20-1019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/b8da6debcb6f/kjr-20-1019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2dc/6609440/dd193221c5c7/kjr-20-1019-g008.jpg

相似文献

1
Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.肝细胞癌及其类似物的不典型表现:如何使用钆塞酸增强肝脏磁共振成像解决具有挑战性的病例。
Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636.
2
Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.应用贝叶斯方法通过 CT 和 MRI 鉴别肝内肿块型胆管细胞癌和肝细胞癌:一项双中心研究。
Eur Radiol. 2020 Nov;30(11):5992-6002. doi: 10.1007/s00330-020-06972-w. Epub 2020 Jun 4.
3
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
4
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
5
Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.肝硬化患者肝内胆管细胞癌:钆塞酸增强磁共振成像和动态 CT 鉴别诊断肝细胞癌。
Radiology. 2017 Mar;282(3):771-781. doi: 10.1148/radiol.2016160639. Epub 2016 Oct 31.
6
Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.基于多变量分析的增强 CT 表现对肿块型肝内胆管细胞癌与低分化肝细胞癌的鉴别诊断
Abdom Radiol (NY). 2016 May;41(5):978-89. doi: 10.1007/s00261-015-0629-z.
7
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.具有类似肝细胞癌放射学强化模式的肝内胆管细胞癌。
Updates Surg. 2020 Jun;72(2):413-421. doi: 10.1007/s13304-020-00750-5. Epub 2020 Apr 22.
8
Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.对比增强计算机断层扫描成像上的瘤内动脉:鉴别肝内胆管癌与低分化肝细胞癌。
Abdom Imaging. 2015 Aug;40(6):1492-9. doi: 10.1007/s00261-015-0352-9.
9
Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.CT 和钆塞酸增强磁共振成像上肝肉瘤样癌的影像学特征。
Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7.
10
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.MRI 特征在肝细胞癌-胆管细胞癌与肿块型肝内胆管细胞癌的对比。
Cancer Imaging. 2018 Feb 27;18(1):8. doi: 10.1186/s40644-018-0142-z.

引用本文的文献

1
Magnetic resonance imaging of hepatocellular carcinoma: a spectrum of uncommon morphologic subtypes, unusual imaging patterns and mimics.肝细胞癌的磁共振成像:一系列不常见的形态学亚型、异常的影像学表现及类似病变
Abdom Radiol (NY). 2025 Jan 4. doi: 10.1007/s00261-024-04773-z.
2
Beyond cholangiocarcinoma: imaging features of mimicking pathologies in the biliary tract.胆管癌之外:胆道模拟病变的影像学特征
Abdom Radiol (NY). 2024 Dec 23. doi: 10.1007/s00261-024-04749-z.
3
Gadoxetic acid disodium (Gd-EOB-DTPA) contrast-enhanced abbreviated magnetic resonance imaging (MRI) for hepatocellular carcinoma surveillance in at-risk patients: a multi-center study in China.

本文引用的文献

1
Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS).诊断 CT/MRI 肝脏影像报告和数据系统(LI-RADS)中的陷阱和问题。
Eur Radiol. 2019 Mar;29(3):1124-1132. doi: 10.1007/s00330-018-5641-6. Epub 2018 Aug 16.
2
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.肝细胞癌-胆管细胞癌混合型:钆塞酸增强磁共振成像的 LI-RADS v2017 分类用于鉴别诊断和预后评估。
Eur Radiol. 2019 Jan;29(1):373-382. doi: 10.1007/s00330-018-5605-x. Epub 2018 Jun 28.
3
Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
钆塞酸二钠(Gd-EOB-DTPA)增强简化磁共振成像(MRI)用于高危患者肝细胞癌监测:一项中国多中心研究
Quant Imaging Med Surg. 2024 Dec 5;14(12):8520-8537. doi: 10.21037/qims-24-941. Epub 2024 Oct 24.
4
Enhancement Patterns of Malignant Gallbladder Masses at Multiphasic Contrast-enhanced CT: Associations With Clinicoradiopathological Features.多期增强CT检查中恶性胆囊肿块的强化模式:与临床放射病理特征的相关性
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):102377. doi: 10.1016/j.jceh.2024.102377. Epub 2024 Jul 16.
5
MRI features of combined hepatocellular-cholangiocarcinoma.肝细胞-胆管细胞癌的磁共振成像特征
Abdom Radiol (NY). 2025 Jan;50(1):169-184. doi: 10.1007/s00261-024-04476-5. Epub 2024 Jul 20.
6
Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.基于钆喷替酸葡甲胺增强 MRI:LR-5 标准类别修改版在肝细胞癌风险患者中的诊断性能。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241256859. doi: 10.1177/15330338241256859.
7
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging.重新评估强化包膜在肝细胞癌成像中的诊断价值。
J Liver Cancer. 2024 Sep;24(2):206-216. doi: 10.17998/jlc.2024.05.01. Epub 2024 May 8.
8
A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors.一种强调薄环状不典型增生结节样强化的改良靶样特征,以提高肝脏影像报告和数据系统(LI-RADS)对恶性肝肿瘤的诊断性能。
J Hepatocell Carcinoma. 2024 Apr 26;11:775-786. doi: 10.2147/JHC.S448257. eCollection 2024.
9
Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma.影像显示的导管周围浸润:在肝内肿块型胆管癌中的诊断及预后作用
Eur J Radiol Open. 2024 Feb 16;12:100554. doi: 10.1016/j.ejro.2024.100554. eCollection 2024 Jun.
10
The Clinical Value of Multimodal Ultrasound for the Differential Diagnosis of Hepatocellular Carcinoma from Other Liver Tumors in Relation to Histopathology.多模态超声在肝细胞癌与其他肝脏肿瘤鉴别诊断中相对于组织病理学的临床价值
Diagnostics (Basel). 2023 Oct 23;13(20):3288. doi: 10.3390/diagnostics13203288.
肝内和肝门部胆管癌的影像学诊断:最新进展与挑战。
Radiology. 2018 Jul;288(1):7-13. doi: 10.1148/radiol.2018171187. Epub 2018 Jun 5.
4
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
5
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
6
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.cHCC-CCA:具有肝细胞和胆管细胞分化的原发性肝癌的共识术语。
Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.
7
Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.辅助成像特征在钆塞酸增强磁共振成像上鉴别硬化型肝细胞癌与肝内胆管细胞癌的价值。
Eur Radiol. 2018 Jun;28(6):2549-2560. doi: 10.1007/s00330-017-5196-y. Epub 2018 Jan 15.
8
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
9
Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.炎症性肝腺瘤:使用肝胆磁共振成像造影剂的特征分析
Magn Reson Imaging. 2018 Apr;47:103-110. doi: 10.1016/j.mri.2017.12.006. Epub 2017 Dec 5.
10
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.支持LI-RADS主要特征用于基于CT和MRI成像诊断肝细胞癌的证据:一项系统评价
Radiology. 2018 Jan;286(1):29-48. doi: 10.1148/radiol.2017170554. Epub 2017 Nov 21.